Treatment strategies in follicular lymphomas: current status and future perspectives.
about
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceuticalTreatment strategies for nodal and gastrointestinal follicular lymphoma: current status and future development.Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphomaThe potential effect of statins on rituximab immunotherapy.Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group.Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives.MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype.Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.Epratuzumab in the therapy of oncological and immunological diseases.Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies.Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting.R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature.Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterationsDissecting the gray zone between follicular lymphoma and marginal zone lymphoma using morphological and genetic features.Prognostic tools in follicular lymphomas.Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.Therapeutic Potential of Resveratrol in Lymphoid Malignancies.Feature-based registration of histopathology images with different stains: an application for computerized follicular lymphoma prognosis.Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.Incidence, risk factors and outcome of histological transformation in follicular lymphoma.Patterns of survival of follicular lymphomas at a single institution through three decades.
P2860
Q24681992-2023D4E6-7D54-4112-9D26-5A0E6A46C21EQ27693252-3615771B-8B3C-4631-87FE-24A5BC473FA4Q29622918-625A1B2E-683A-4490-821B-01202A4E1A1DQ33325581-875849E0-6D85-4FDA-99C0-151CD8BDBB64Q33378309-BC10A186-0779-40D9-BC85-30CAC28428E0Q34700655-D34AC03B-2CDB-4B1B-BEC6-2ABF2E231BF2Q35553338-A9AE7E8B-E303-434F-BC63-CFC891365C74Q36445879-BBC7D2A2-ECC9-4F04-BE5B-7A4DCF71F45EQ36636619-AE069221-77FA-4A2A-B443-0934F80979D4Q36832137-A4A9D5F1-390A-4716-A0BE-DD4E6F3D4A48Q36923861-824BCB31-DB42-46FE-9A2A-55896C68AC92Q37158679-675F3700-AFB9-4AEE-9B3E-F12839F524CFQ37275890-0713A88D-F239-431D-BAD8-394FB1F84A8CQ37377920-1B269DD6-C57D-4F0B-9532-206D91BC7242Q37810119-8C6DF315-2A9A-4702-9B7C-8507D53842B4Q38001363-4C39915A-A9C8-435A-A7C1-B76B4A115BBDQ38793825-868A2ABB-A32A-42A3-A290-E258403EA5EFQ42134129-A7D02FAC-A253-4BFF-B81C-FFB1EE9CCEF5Q43825649-D7664AFB-E2A4-4442-A8CB-D9327C703834Q45286370-53C7AD88-F919-4451-A168-54503DC8CB59Q51767765-58D52427-EE57-4A3C-A9AB-ED257A253367
P2860
Treatment strategies in follicular lymphomas: current status and future perspectives.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Treatment strategies in follicular lymphomas: current status and future perspectives.
@ast
Treatment strategies in follicular lymphomas: current status and future perspectives.
@en
type
label
Treatment strategies in follicular lymphomas: current status and future perspectives.
@ast
Treatment strategies in follicular lymphomas: current status and future perspectives.
@en
prefLabel
Treatment strategies in follicular lymphomas: current status and future perspectives.
@ast
Treatment strategies in follicular lymphomas: current status and future perspectives.
@en
P2093
P356
P1476
Treatment strategies in follicular lymphomas: current status and future perspectives.
@en
P2093
Christian Buske
Christina Nickenig
Georg Lenz
Martin Dreyling
Michael Unterhalt
Oliver Weigert
Roswitha Forstpointner
Wolfgang Hiddemann
P304
P356
10.1200/JCO.2005.07.019
P407
P577
2005-09-01T00:00:00Z